# If Dexcom moves, who benefits? How far does the value-chain ripple reach?
Canonical: https://valuechain.wiki/dexcom · Facet: ripple · Updated: 2026-09-23T09:44:36.635703+00:00 · Source: ValueChain.wiki (cited money-flow graph)

**Citable summary**: Per the valuechain.wiki graph, Dexcom is directly linked to 2 companies (0 supply, 2 revenue relationships) and reaches 4 companies within two hops; the links are backed by 8 dated sources, 3 of them primary filings (as of 2026-09-23).

Dexcom operates across Continuous glucose sensing platform. After -14.7% in 2025, it rebounded +32.4% in 2026. The stock (+32.4%) and its demand side (avg +16.1%) are moving in step. Among connected nodes the furthest ahead is Cardinal Health, Inc. (+21.1%) and the furthest behind is McKesson Corporation (+11%). If chain logic explains the gap, the laggard is the next propagation candidate; if not, the link itself deserves a second look. It relies on external contract manufacturing and Verily glucose-monitoring technology and intellectual property, while also making strategic equity investments in adjacent health-data businesses.

## Demand chain (leading)
- T1 Cardinal Health, Inc. (https://valuechain.wiki/cardinal-health.md)
- T2 CVS Health (https://valuechain.wiki/cvs-health.md)
- T3 Elevance Health, Inc. (https://valuechain.wiki/elevance-health.md)
- T1 McKesson Corporation (https://valuechain.wiki/mckesson.md)
- T2 Walmart Inc (https://valuechain.wiki/walmart.md)
- T3 UnitedHealth Group Incorporated (https://valuechain.wiki/unitedhealth-group.md)

---
Full node: https://valuechain.wiki/dexcom.md · JSON: https://valuechain.wiki/dexcom.json